David Gómez‐Almaguer

Author

Universidad Autónoma de Nuevo León ORCID

Also Known As

D Gomez-Almaguer, D Gómez-Almaguer, D. Gomez-Almaguer, D. GÓMEZ-ALMAGUER, D. Gómez-Almaguer, D. Gómez‐Almaguer, D. Gömez-Almaguer, David ALMAGUER, David G[oacute]mez-Almaguer, David Gomez-Almaguer

623

Publications

5.6K

Citations

H-Index

120

Concepts

All Affiliations

Universidad Autónoma de Nuevo León Clínica Ruiz Hospital Universitario Dr José Eleuterio Gonzalez Universidad Popular Autónoma del Estado de Puebla

About

David Gómez‐Almaguer is an author at Universidad Autónoma de Nuevo León specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	57	1.7K
2	Blood Transplantation	13	16	492
3	Health Sciences	11	16	495
4	Public Health	10	10	287
5	Cell Biology	4	4	111

David Gómez‐Almaguer

131

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL Eduardo Magalhães Rego, Haesook T. Kim, Guillermo J. Ruíz‐Argüelles, Blood	2013	148
Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults David Gómez‐Almaguer, Miguel Ángel Herrera-Rojas, José Carlos Jaime‐Pérez, Blood	2014	99
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, JAMA	2024	90
Results of an outpatient‐based stem cell allotransplant program using nonmyeloablative conditioning regimens Guillermo J. Ruíz‐Argüelles, David Gómez‐Almaguer, Alejandro Ruı́z-Argüelles, American Journal of Hematology Cell TherapyTransplant-related MortalityDeveloped Chronic GvhdImmunotherapyRegenerative Medicine	2001	89
The effect of intra‐articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis Domingo Garay‐Mendoza, Laura Villarreal‐Martínez, Alejandra Garza‐Bedolla, International Journal of Rheumatic Diseases	2017	89
Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease David Gómez‐Almaguer, Guillermo J. Ruíz‐Argüelles, Luz Tarín-Arzaga, Biology of Blood and Marrow Transplantation	2007	81
Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients José Gerardo González‐González, Leonor Mireles-Zavala, René Rodríguez‐Gutiérrez, Diabetology & Metabolic Syndrome	2013	75
Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias David Gómez‐Almaguer, Manuel Solano-Genesta, Luz Tarín‐Arzaga, Blood	2010	74
Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases David Gómez‐Almaguer, GJ Ruiz-Argüelles, Alejandro Ruı́z-Argüelles, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationHematology	2000	74
Reduced-intensity stem cell transplantation in children and adolescents: The Mexican experience David Gómez‐Almaguer, Guillermo J. Ruíz‐Argüelles, Luz Tarín-Arzaga, Biology of Blood and Marrow Transplantation	2003	71

Page 1